enGene Therapeutics Inc.

Biological Products, (No Diagnostic Substances) | SIC: 2836
Phone: (514) 332-4888
CIK: 0001980845
State of Inc.: Z4
Tickers:
  • Nasdaq:ENGN
  • Nasdaq:ENGNW

Form: ARS

Filing Date: 08 May 2026
Report Date: 31 Oct 2025
Accepted: 08 May 2026 02:08 p.m.
Accession Number: 0001140361-26-020034
Act: 34
File Number: 001-41854
Film Number: 26958366

Documents

Primary Document: ARS
Accepted: 08 May 2026 02:08 p.m.